Clinical Trials Information System (CTIS)

📣Attention all clinical trial sponsors who are planning to conduct a study in the EU or EEA!

Beginning on January 31, 2023, the Clinical Trials Information System (CTIS) must be used to submit any new clinical trial application in these regions. This new process permits a single application to secure authorizations in up to 30 countries! Watch the following webinar part to learn more about the first steps in CTIS.

Click here to watch the full webinar organized by the Polish Association for Good Clinical Practice (GCPpl).

Questions?

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Blog Article

Essential Requirements for Adaptive Designs in Clinical Trials

Adaptive design in clinical trials is a dynamic and innovative approach, but it requires certain key elements to ensure its successful implementation. Efficiency and Integrity The purpose of an adaptive trial design is to increase efficiency without compromising the integrity and validity of the results. For this to be accomplished, extensive and adequately maintained clinical […]

Blog Article

The Potential of Adaptive Design in Clinical Trials

Did you know? Adaptive design offers numerous benefits that streamline the drug-development process and bring life-changing medications to patients more rapidly. Adaptive Study Design Help With: Reducing the costs of drug development Contributing to reducing the length of the trial Reducing the time to bring a drug to the market Allowing patients to access to […]

Clinical Trials Information System (CTIS)

Newsletter subscription resources

Top 10 Rheumatology Clinical Trial Topics at the Upcoming Edition of ACR 2024

Essential Requirements for Adaptive Designs in Clinical Trials

The Potential of Adaptive Design in Clinical Trials